NCT07132515

Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC

Efficacy and Safety of Anticoagulant Therapy for Portal Vein Thrombosis In Cirrhosis Patients With and Without Hepatocellular Carcinoma

• Status: Recruiting
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Mansoura University · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

We will give an anticoagulant against portal vein thrombosis, and watch for the results.

Conditions

• Cirrhosis
• HCC - Hepatocellular Carcinoma
• Portal Vein Thrombosis

Interventions

Type	Name	Description
DRUG	Enoxaparin, warfarrin, or apixaban	Enoxaparin, warfarrin, or apixaban

Timeline

• Start date: 2023-08-15
• Primary completion: 2025-08-01
• Completion: 2025-08-01
• First posted: 2025-08-20
• Last updated: 2025-08-20

Locations

1 site across 1 country: Egypt